Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol

Actualización del papel de la quimioterapia endovesical en el cáncer de vejiga no músculo-invasivo

(2018) M. Unda-Urzaiz et al.   Actas Urologicas Espanolas

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

The safety and efficacy of gemcitabine for the treatment of bladder cancer

(2016) Katrin Schlack et al.   Expert Review of Anticancer Therapy

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Determination of serum brassicasterol in spontaneously hypertensive rats stroke-prone fed a high-ergosterol diet by ultra performance liquid chromatography

(2015) Takaaki Ohtsubo et al.   EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY

The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer

(2012) Y. Li et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY